Moemi Hayashi

Nagoya University

Papers

2

Total Citations

320

H-Index

2

About

Moemi Hayashi is a pioneering researcher in the emerging field of plasma oncology, where she has made transformative contributions to the selective treatment of ovarian cancer. Her most influential work, published in 2012 and cited over 300 times, demonstrates that nonequilibrium atmospheric pressure plasma (NEAPP) can selectively induce apoptosis in ovarian cancer cells while sparing normal fibroblasts. This breakthrough revealed a novel, non-thermal approach to cancer therapy, showing that continuous plasma treatment to a single spot on a culture dish could detach and kill malignant cells without harming healthy tissue. Hayashi’s research bridges physics and medicine, offering a potential alternative to conventional chemotherapy with fewer side effects. Her findings have inspired further investigations into plasma-based therapies for other cancers and have positioned her as a key figure in the development of cold atmospheric plasma as a clinical tool. Through her rigorous experimental design and clear demonstration of selective cytotoxicity, Hayashi has laid the groundwork for future translational studies, making her work essential reading for students and researchers interested in non-invasive cancer treatments and the biomedical applications of plasma physics.

Research Focus

Key Achievements

2
H-Index
2
Papers
320
Total Citations
160
Avg Citations/Paper
🏆 Most Cited Paper
Selective killing of ovarian cancer cells through induction of apoptosis by nonequilibrium atmospheric pressure plasma
314 citations · 2012
📈 Most Prolific Year: 2012 (2 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Nagoya University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago